Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Immunity bio doing well

<< Previous

Bullboard Posts

Next >>

Post by DJDawgon Feb 14, 2022 8:56pm

357 Views

Post# 34428447

Immunity bio doing well

This seems to be the main competitions. If I'm reading it correctly, 71% CR is the new standard to match or beat. Obviously this drug is being used WITH BCG and involves lots of instillations.

For TLD-1433, the optimized numbers will match or beat off of one or two treatments but will take time to demonstrate that to the wider world.

https://finance.yahoo.com/news/immunitybio-announces-over-24-months-221700126.html

Look forward to Eoganacht and others to weigh in on these updates.

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario